Oncotelic Therapeutics Inc
OTC:OTLC
Oncotelic Therapeutics Inc
OTC:OTLC
Price:
0.0382 USD
-1.55%
Market Closed
Updated:
May 11, 2024
Oncotelic Therapeutics Inc
Total Other Income
|
Oncotelic Therapeutics Inc
Total Other Income Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Oncotelic Therapeutics Inc
OTC:OTLC
|
Total Other Income
$72.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Oncotelic Therapeutics Inc's Total Other Income?
Total Other Income
72.3k
USD
72.3k
USD
Based on the financial report for Dec 31, 2023, Oncotelic Therapeutics Inc's Total Other Income amounts to 72.3k USD.
What is Oncotelic Therapeutics Inc's Total Other Income growth rate?
Total Other Income CAGR 1Y
-86%
-86%
Over the last year, the Total Other Income growth was -86%.
You don't have any saved screeners yet
